Sutro Biopharma Net Interest Income History
| STRO Stock | USD 21.25 -0.08 -0.38% |
Net Interest Income | First Reported 2019-03-31 | Previous Quarter -8.2 M | Current Value -8.4 M | Quarterly Volatility 5.1 M |
Macro event markers
Latest Sutro Biopharma's Net Interest Income Growth Pattern
The historical Net Interest Income for Sutro Biopharma spanning the full 10-year history is displayed in the chart. Sustained recovering momentum across multiple periods strengthens confidence in the directional signal. Inflection points in the chart may coincide with changes in strategy, market conditions, or accounting treatment. The pace of change matters as much as the direction when assessing Sutro Biopharma's financial trajectory. Flat stretches in Sutro Biopharma's Net Interest Income may reflect operational stability or a pause between growth phases.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
Net Interest Income Trend Statistics
| Arithmetic Mean | 2,532,907 | |
| Coefficient Of Variation | 241.88 | |
| Mean Deviation | 4,562,563 | |
| Median | 251,000 | |
| Standard Deviation | 6,126,674 | |
| Sample Variance | 37.5T | |
| Range | 18.7M | |
| R-Value | 0.58 | |
| Mean Square Error | 26.4T | |
| R-Squared | 0.34 | |
| Significance | 0.01 | |
| Slope | 707,520 | |
| Total Sum of Squares | 600.6T |
Sutro Biopharma Net Interest Income History
| 2026 | 16.1 M | ||
| 2025 | 15.4 M | ||
| 2024 | 13.4 M | ||
| 2023 | -2.2 M | ||
| 2022 | 109 K | ||
| 2021 | -2.6 M | ||
| 2020 | -2.6 M | ||
| 2019 | 4.1 M | ||
| 2018 | -7000.0 | ||
| 2017 | -339 K |
Related Accounts
| Last Reported | End Of Year Estimate | ||
| Net Interest Income | 15.4 M | 16.1 M | |
| Interest Income | 51.1 M | 53.6 M | |
| Interest Expense | 35.7 M | 37.5 M | |
| Interest Coverage | 4.14 | 4.35 | |
| Interest-Bearing Debt Per Share | -2.65 | -2.52 |
Methodology, Assumptions & Data Sources
Below you can see Sutro Biopharma's Net Interest Income across recent years. Big swings can signal sensitivity to the broader economy.
Sutro Biopharma metrics are compiled from periodic company reporting and market reference feeds and normalized before display. Analyst inputs may be included when coverage is available. Not all fields update in real time. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.